Clinical dilemmas in dialysis: Managing the hypotensive patient setting the stage

American Journal of Kidney Diseases

Volumn 38, Issue 4 SUPPL. 4, 2001, Pages

  Schreiber Jr, Martin J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute coronary syndrome; Arrhythmogenicity; Autoregulation dysfunction; Intradialytic hypotension (IDH); Pharmacologic intervention; Thrombogenicity

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; CALCIUM; CARNITINE; EPHEDRINE; FLUDROCORTISONE; MIDODRINE; PSEUDOEPHEDRINE; SERTRALINE; VASOPRESSIN;

ARRHYTHMOGENESIS; BLOOD VESSEL INJURY; CARDIOVASCULAR AUTOREGULATION; DIALYSATE; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPOTENSION; KIDNEY FAILURE; MORTALITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; TECHNOLOGY; THROMBOGENICITY; VASCULAR ENDOTHELIUM;

EID: 0034776068     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.28089     Document Type: Review

References (62)

1. Further development of a coil kidney: Disposable artificial kidney
2. Trends in treatment and survival for hemodialysis patients in the United States
3. Hemodynamic instability during hemodialysis
4. Hemodynamic criteria for adequacy of volume regulation and prevention of myocardial impairment in chronic hemodialysis patients
5. Nonocclusive mesenteric ischemia in a patient on maintenance hemodialysis
6. Sudden and cardiac death rates in hemodialysis patients
7. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients
8. Hypertension does not affect survival in hemodialysis patients
9. Reply from the authors
10. Hypertension is not adequately controlled in hemodialysis patients
11. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients
12. Baseline blood pressure and other variables influencing survival on haemodialysis of patients without overt cardiovascular disease
13. Is hypertension a mortality risk factor in dialysis?
14. Hypertension in the hemodialysis population? High time for answers
15. Hypertension in the haemodialysis population: Any relationship to 2-years survival?
16. "U" curve association of blood pressure and mortality in hemodialysis patients
17. Benefits and potential harm of lowering high blood pressure
18. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients
19. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
20. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
21. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
22. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients
23. The pathogenesis and spectrum of acute coronary syndromes: From plaque formation to thrombosis
24. Cardiac arrhythmias in end-stage renal disease: Prevalence, risk factors, and management
25. Coronary risk in patients with end-stage renal disease: Interaction of hypertension with hyperlipidemia
26. The role of hypertension in hemodialysis-associated atherosclerosis
27. Alterations of arterial function in end-stage renal disease
28. Endothelin and cardiovascular remodeling in end-stage renal disease
29. Impact of aortic stiffness on survival in end-stage renal disease
30. Mechanical factors affecting hemostasis and thrombosis
31. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor- 1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients
32. Plasma hypercoagulability in haemodialysis patients: Impact of dialysis and anticoagulation
33. Mechanism on disorders of coagulation and fibrinolysis in diabetes
34. Cerebral, coronary, and renal blood flows during hemorrhagic hypotension in anesthetized miniature swine
35. Coronary adjustments to graded hypotension in rabbits
36. Morphology of coronary atherosclerotic lesions in patients with end-stage renal disease
37. Coronary haemodynamics in left ventricular hypertrophy
38. Reduction of coronary reserve: A mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries
39. Coronary reserve: Concept and physiological variations
40. A critical view of coronary reserve
41. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients
42. Impaired coronary flow reserve in NIDDM: A possible role for diabetic cardiopathy in humans
43. Acute blood pressure reduction causes an impairment of left ventricular function in hypertensive patients with coronary heart disease and left ventricular hypertrophy
44. Coronary blood flow during variation in coronary perfusion pressure
45. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: The Framingham study
46. Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia
47. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle
48. Determinants of ventricular arrhythmias in hemodialysis patients. Evaluation of the effect of arrhythmogenic substrate and autonomic imbalance
49. Autonomic neuropathy predisposing to arrhythmias in hemodialysis patients
50. QT dispersion before and after hemodialysis
51. Mechanisms and models to predict a QTc effect
52. Preoperative blood transfusion in the safe surgical management of pheochromocytoma: A review of 46 cases
53. Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
54. The epidemiological association between BP and stroke: Implications for primary and secondary prevention
55. Orthostatic hypotension as a risk factor for stroke: The Atherosclerosis Risk in Communities (ARIC) study
56. Pathological regulation in cerebral ischemia
57. Autoregulation of cerebral blood flow in orthostatic hypotension
58. Hemodialysis causes severe orthostatic reduction in cerebral blood flow velocity in diabetic patients
59. Adjustment of reduced arterial blood pressure - A tool for investigations into gradually reduced brain function